Navigation Links
Watson and Barr Settle Lawsuit Over Oxytrol(R)
Date:10/28/2009

CORONA, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that its subsidiary Watson Laboratories, Inc. has reached a settlement with Barr Laboratories, Inc. on outstanding patent litigation related to Watson's Oxytrol® (Oxybutynin Transdermal System, 3.9mg/24hr.) product.

On August 19, 2008, Barr submitted an Abbreviated New Drug Application (ANDA) seeking approval to market a generic version of Oxytrol®. Under terms of the settlement agreement, Watson has granted Barr a royalty-bearing license to the U.S. patents covering Oxytrol® to commence marketing a generic equivalent product on April 26, 2015, or earlier in certain circumstances.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc., (NYSE: WPI) is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of branded pharmaceuticals focused on Urology, Gynecology and Nephrology (Medical).

Forward-Looking Statement

Any statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements. Actual results may differ materially from Watson's current expectations depending upon a number of factors affecting Watson's business. These factors include, among others, the difficulty of predicting the timing and outcome of litigation; risks that resolution of patent infringement litigation through settlement could result in investigations or actions by private parties or government authorities; the impact of competitive products and pricing; and other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's Quarterly Report on Form 10-Q for the period ended June 30, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)

SOURCE Watson Pharmaceuticals, Inc.


'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
2. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
5. Watson Launches Generic Biaxin(R) XL
6. Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R)
7. Faced With Federal Prosecution, MountainView Agrees to Stop Harassment of RNs in Settlement With Labor Board
8. Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
9. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
10. Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds
11. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2020)... ... August 03, 2020 , ... Seattle’s Infectious Disease Research ... and restate IDRI’s license with Immune Design, a wholly owned subsidiary of Merck ... the parties have agreed to modify the licensed fields and indications under which ...
(Date:8/3/2020)... ... August 03, 2020 , ... LaVoieHealthScience (LHS), an integrated ... announced that Donna L. LaVoie, President, CEO and Founder of LHS, has been named ... , Since 2005, the PharmaVOICE 100 has honored more than 1,500 industry executives for ...
(Date:7/31/2020)... ... 2020 , ... As one of the most prominent and popular Houston area ... TX, with a wide range of professional dental services for many years. The recently ... is not far from the previous clinic location. Dr. Simone Ellis’s modern, cutting-edge dental ...
Breaking Medicine Technology:
(Date:8/7/2020)... ... August 07, 2020 , ... Alexandria Dental Health ... by Dr. Mojgan Mazhari, this well-respected practice offers advanced smile solutions to meet ... is among an exclusive group of dental practices with a large number of ...
(Date:8/5/2020)... ... August 05, 2020 , ... ... (SEL) program, has been named to the inaugural list of Best Digital Tools ... , This recognition honors electronic resources that provide enhanced learning and curriculum development ...
(Date:8/5/2020)... Calif. (PRWEB) , ... August 05, 2020 , ... ... America’s healthcare system has repeatedly risen to unprecedented challenges. Regardless of the obstacle ... such as personal protective equipment (PPE) and the cancellation or postponement of all ...
(Date:8/5/2020)... ... August 05, 2020 , ... The Veterinary Cooperative ... of the largest veterinarian-owned purchasing Cooperative in the United States. , Hamele has ... she gained extensive knowledge and experience in the animal health industry. In her ...
(Date:8/5/2020)... ... August 04, 2020 , ... ... with Autism Spectrum Disorder (ASD) in Wisconsin, is delighted to announce the grand ... the opening of their newest center, Total Spectrum now proudly serves ten different ...
Breaking Medicine News(10 mins):